SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is generating significant investor interest as the community awaits further clinical data following its recent pancreatic cancer trial presentation at DDW 2026. Bulls are focusing on a series of upcoming catalysts, including the highly anticipated ASCO annual meeting and interim data from the REGAIN glioblastoma trial, as the company works toward broader scientific validation for its Alpha DaRT platform.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is experiencing heightened volatility and intense social media chatter as the community debates whether recent price pullbacks represent a healthy consolidation or a deeper unwind. Investors remain divided, with some aggressively accumulating at current levels while others express frustration over the token's performance compared to broader market trends.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is experiencing heightened volatility driven by a public proxy battle between its board and founder Chip Wilson, alongside concern over the new CEO's previous track record and a broader retail sector slump. While many investors are expressing frustration over the persistent decline, others are actively accumulating shares, viewing the current low valuation and institutional buybacks as a contrarian opportunity for a long-term turnaround.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is trending amid heightened volatility as investors weigh disappointing delivery guidance against potential catalysts from upcoming product launches like the i6 SUV. The community remains deeply divided, with some traders shorting the stock on concerns over declining market share and margin pressure, while others view the current price as a value opportunity for a long-term turnaround.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors gear up for the company's first earnings report since its public listing, with the community closely watching for updates on revenue scaling and the impact of recent government and defense contract wins. Market participants are actively debating the stock's long-term potential as a quantum sector leader, weighing its institutional backing and technological differentiation against short-term price volatility.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing significant volatility and upward momentum driven by reports of high-profile institutional interest, including an investment by Donald Trump, and a positive analyst upgrade from BofA. While some investors see this as an opportunity for a major SaaS sector rotation and AI-driven recovery, others in the community remain cautious, debating whether this is a sustainable trend or just a narrative-driven rally prone to potential pullbacks.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is experiencing significant volatility and trading near 52-week lows as investors weigh concerns about cooling housing demand and rising interest rates ahead of upcoming earnings. While bearish sentiment persists due to broader macroeconomic headwinds, the community remains divided, with some traders hunting for a reversal based on technical patterns while others warn of further downside risks.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate whether the current price represents a deep-value opportunity or a value trap, with the community closely tracking its pivot into agentic AI orchestration and enterprise integration partnerships. While some participants express frustration over persistent share price weakness and perceived manipulation, others are aggressively accumulating shares, pointing to the company's strong cash position, lack of debt, and potential for long-term growth as the market rotates toward quality AI software.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is seeing significant retail interest fueled by a massive, open-market insider purchase by a director, which has sparked heated debates among the community regarding a potential short squeeze. While bulls are highlighting the stock's deep undervaluation, high free cash flow potential, and aggressive share buybacks, bears remain focused on the company's substantial debt load and declining subscriber base.

Invesco CurrencyShares Australian Dollar Trust - Invesco CurrencyShares Australian Dollar Trust

Invesco CurrencyShares Australian Dollar Trust

The Australian Dollar is currently a focal point for traders navigating divergent central bank policies and sensitivity to shifting commodity demand and trade tensions. Community discussions are heavily centered on macro-economic data, with participants debating whether current levels represent a sustainable breakout or a potential reversal in the face of ongoing geopolitical uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IMAB  @Tika1 @jayshree4201Twits  Unless nobody cares. I am not seeing any huge differentiator with their data...looks good but going to need more than that IMO.  
And this opinion applies to many biotechs - while it might seem early, some of these that have drifted down since the beginning of the year I see more downward movement motivated by: 
Summer doldrums (sell in May then go away) 
Blips in June (ASCO conference spiking 1 or 2) 
Drifting down more 
Spikes in Sept (transient for a few) 
Nov. Tax loss selling 
I could see NBP IMAB getting down to 1.2 by then. 
 
Dec - Feb 2027 some up 100-200% if one times the bottom perfectly + a bit of luck

Bill Walker

LabPsycho

@jayshree4201Twits I started buying this. This is too cheap for a phase 3-ready asset company.

StockTwits Web

Tika

I-Mab - ADR

  Unless nobody cares. I am not seeing any huge differentiator with their data...looks good but going to need more than that IMO.  
And this opinion applies to many biotechs - while it might seem early, some of these that have drifted down since the beginning of the year I see more downward movement motivated by: 
Summer doldrums (sell in May then go away) 
Blips in June (ASCO conference spiking 1 or 2) 
Drifting down more 
Spikes in Sept (transient for a few) 
Nov. Tax loss selling 
I could see NBP IMAB getting down to 1.2 by then. 
 
Dec - Feb 2027 some up 100-200% if one times the bottom perfectly + a bit of luck

@LabPsycho As you know, I See the differentiation in all Assets within selected indications. ABL just pitched the 4-1BB platform to give an example. https://www.ablbio.com/kr/company/news_view/979?keyword=&amp;sort_desc=date

I keep on adding, with expected short term newsflow for Announcement of ESMO GI presentation, q1 report, ESMO GI and upcoming Uli topline data end of Q2 / Q3.

이중항체 전문기업 에이비엘바이오(대표 이상훈)는 5월 11일부터 15일(현지시간)까지 미국 보스턴(Boston)에서 개최되는 PEGS 서밋(The Essential Protein & Antibody Engineering Summit)에 참석해 4-1BB 기반 이중항체 플랫폼 그랩바디-T(Grabody-T)를 소개한다고 6일 밝혔다. PEGS 보스턴 서밋은 생물의약품 및 단백질 공학 관련 국제 행사로, 다양한 제약ㆍ바이오 기업 관계자들이 모여 해당 분야의 혁신 기술과 새로운 신약 개발 전략과 성공 사례 등을 공유하는 자리다.

Ablbio

ABL Bio

StockTwits for iOS

 As you know, I See the differentiation in all Assets within selected indications. ABL just pitched the 4-1BB platform to give an example. 



I keep on adding, with expected short term newsflow for Announcement of ESMO GI presentation, q1 report, ESMO GI and upcoming Uli topline data end of Q2 / Q3.